GLP-1 RECEPTOR AGONIST

Clinical trials for GLP-1 RECEPTOR AGONIST explained in plain language.

Never miss a new study

Get alerted when new GLP-1 RECEPTOR AGONIST trials appear

Sign up with your email to follow new studies for GLP-1 RECEPTOR AGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for stalled weight loss after surgery

Disease control Recruiting now

This study is testing a medication called efsubaglutide alfa to see if it can help people who are still obese six months after having metabolic (weight loss) surgery. It will involve 60 participants who will receive either the real drug or a placebo (dummy treatment) to compare r…

Matched conditions: GLP-1 RECEPTOR AGONIST

Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated Mar 11, 2026 14:52 UTC

GLP-1 RECEPTOR AGONIST

Get alerted when new GLP-1 RECEPTOR AGONIST trials appear

New hope for stalled weight loss after surgery